DOJ Sues Drugmaker Over Unapproved Misbranded Drugs

Law360, New York (June 20, 2013, 6:53 PM EDT) -- The U.S. Department of Justice has hit Sage Pharmaceuticals Inc. with a misbranding suit in Louisiana federal court accusing the company of unlawfully manufacturing and selling several drugs without regulatory approval, it announced Thursday.

Shreveport, La.-based Sage had made and sold at least eight drugs without FDA approval, despite knowing its actions were unlawful, in violation of the Food, Drug and Cosmetic Act, according to the complaint, filed on behalf of the U.S. Food and Drug Administration.

“As demonstrated by the results of FDA’s most recent...
To view the full article, register now.




Case Information

Case Title

USA v. Sage Pharmaceuticals Inc et al

Case Number



Louisiana Western

Nature of Suit

Other Statutory Actions


S Maurice Hicks

Date Filed

June 20, 2013

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.